Can You Really Trust City Forecasts For HSBC Holdings plc, GlaxoSmithKline plc and Vodafone Group plc?

Can City estimates for HSBC Holdings plc (LON: HSBA), GlaxoSmithKline plc (LON: GSK) and Vodafone Group plc (LON: VOD) be trusted?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

HSBC (LSE: HSBA), GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) and Vodafone (LSE: VOD) (NASDAQ: VOD.US) all look to be to be attractively priced based on City forecasts for the next two years. The problem is, City analysts can — and do — often get these forecasts wrong, which can sometimes leave investors in a sticky position.

Indeed, over the past year alone City analysts have reduced their earnings forecast figures for HSBC, Glaxo and Vodafone by a double-digit percentage. This leaves me wondering if there could be further reductions to come. 

Revising lower

cityHSBC, Glaxo and Vodafone are three FTSE 100 behemoths. Most investors will have at least one of these stalwarts in their portfolios. As all three companies currently support a dividend yield in excess of 4.5%, compared to the FTSE 100 average of less than 3.5%, they make a dependable backbone to build a portfolio around.

Still, investors should be careful, as the City has been reducing its earnings forecasts for these companies over the past year, which has pushed valuations higher.

Vodafone has been the most affected by these ‘moving forecasts’. This time last year the City was expecting Vodafone to report earnings per share of 29p during 2014, followed by earnings of 32p per share during 2015. These forecasts included Vodafone’s share of Verizon Wireless‘s income.

Excluding the Verizon Wireless income, and the share consolidation, the City was expecting Vodafone to report earnings per share of 9p during 2014 and then 10p during 2015. However, over the past few months these estimates have fallen further and the City now expects Vodafone to report earnings of  just 6.8p per share this year and 7.2p during 2015. 

Continual adjustment

Surprisingly, over the past year, Glaxo has seen its earnings forecasts adjusted lower by a shocking 34%! The City now expects the company to report earnings of 96p per share this year — this time last year earnings of 118p per share were expected. Similarly, 2015 forecasts have fallen from 130p per share down to 101p per share. 

HSBC has also seen its earnings forecasts revised lower, although the adjustment has only been less severe. For 2014, City analysts have adjusted the bank’s earnings lower from 62p per share, down to 54p per share. Further, 2015 earnings estimates have been downgraded by 10p, from 68p per share, to 58p per share. 

What does it mean?

How does it affect investors? Well, for a start falling earnings estimates have changed company valuations. Unfortunately, this could mean that investors see valuations change for the worse as analysts revise forecasts down further. 

However, dividend investors do not need to worry. In most cases City dividend forecasts are correct, as they are based on figures supplied by company management teams.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns shares of GlaxoSmithKline. The Motley Fool recommends GlaxoSmithKline.

More on Investing Articles

Investing Articles

How much passive income could I earn if I buy Tesco shares today?

Buying Tesco shares has rewarded investors with solid dividends for decades, and the foreacast shows more years of growth ahead.

Read more »

Investing Articles

How do I build a million pound Stocks and Shares ISA?

With a regular savings plan, a decent investment strategy, and a long-term mindset, a £1m Stocks and Shares ISA is…

Read more »

Young black woman in a wheelchair working online from home
Investing Articles

7 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Investing Articles

If I invest £15,000 in National Grid shares, how much passive income would I receive?

National Grid has long been one of the FTSE 100's most reliable dividend stocks, dishing out passive income year after…

Read more »

BUY AND HOLD spelled in letters on top of a pile of books. Alongside is a piggy bank in glasses. Buy and hold is a popular long term stock and shares strategy.
Investing Articles

How much passive income could I earn from 359 Diageo shares?

After a year of share price declines, Stephen Wright looks at whether a FTSE 100 Dividend Aristocrat could be a…

Read more »

Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
Investing Articles

Could the Rolls-Royce share price surge be back on again?

The Rolls-Royce share price peaked in early 2024, and then started to fall back... and then picked up again. Here's…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

Up 40% in a month! But have I left it too late to buy this top FTSE 100 performer?

This dividend growth stock has smashed the FTSE 100 over the last month. Yet Harvey Jones is approaching it with…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

My two favourite FTSE passive income stocks have plunged in 2024. Time to buy more?

Harvey Jones went big on these two FTSE 100 dividend stocks last year, hoping to generate bags of passive income.…

Read more »